Novartis raises sales growth target to 5% per year until 2027
Novartis raised its sales growth target to 5% a year to 2027, citing demand for innovative medicines following the spin-off of its generics business. The medium-term target, which excludes any currency effects, is mainly driven by six drugs led by Kisqali, the Swiss drugmaker said at a presentation.
POPULAR POSTS
Earthquakes and emissions undermine the idea of carbon storage in Texas
December 17, 2024
Rescuers search for cyclone survivors in devastated Mayotte
December 17, 2024
“Gilmore Girls” airs for a second season on Hulu
December 17, 2024
LIVE STREAM